Skip to main content

Vanderbilt Ingram Cancer Center Archives

Ingram sees recent cancer diagnosis as second chance

Apr. 19, 2018—“When it’s you, it’s a whole different feeling,” Orrin Ingram said, gazing at logs burning in the fireplace.

Read more


Cancer Center’s annual scientific retreat set for May 3

Apr. 18, 2018—The potential link between the body’s microbiome and cancer is the topic of this year’s Vanderbilt-Ingram Cancer Center (VICC) Scientific Retreat. The annual event, which features leading cancer investigators from the National Cancer Institute (NCI) and several prominent universities will be held Thursday, May 3, 8 a.m. to 3 p.m. at the Vanderbilt Student Life Center.

Read more


Agreement renewal bolsters liver tumor research

Apr. 12, 2018—Sirtex Medical Ltd. has renewed a grant award to Dan Brown, MD, professor of Radiology and Radiological Sciences and chief of Interventional Oncology, and his Vanderbilt Health colleagues, for a research program designed to treat patients with liver tumors that cannot be addressed with surgery.

Read more


VICC breast cancer leaders named Komen Scholars

Apr. 12, 2018—Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar for her leadership in breast cancer research.

Read more


Entertainers’ support strengthens VICC melanoma research efforts

Apr. 12, 2018—Henry Paul and Dave Robbins, members of country music group BlackHawk, as well as southern rock band The Outlaws, recently donated $40,000 to Vanderbilt-Ingram Cancer Center (VICC) in support of melanoma research. Since 2006, the band members have generated more than $100,000 for VICC.

Read more


VICC to host symposium on neurofibromatosis April 21

Apr. 12, 2018—Vanderbilt-Ingram Cancer Center (VICC) will host a special event for patients and families affected by neurofibromatosis (NF), a genetic disorder that can cause tumors in the nervous system. The Neurofibromatosis Patient and Family Symposium will be held Saturday, April 21, 9 a.m. – 1 p.m., at the VICC 8th floor conference center in the Preston Research Building, 2220 Pierce Ave.

Read more


VICC to host neurofibromatosis event April 21

Apr. 5, 2018—Vanderbilt-Ingram Cancer Center (VICC) will host a special event for patients and families affected by neurofibromatosis (NF), a genetic disorder that can cause tumors in the nervous system.

Read more


Cancer immunotherapy drugs linked with more serious heart effects

Mar. 12, 2018—Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.

Read more


VICC study sheds new light on Von Hippel-Lindau syndrome

Mar. 8, 2018—Investigators at Vanderbilt-Ingram Cancer Center (VICC) and the Virginia Tech Carilion Research Institute (VTCRI) have revealed a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs.

Read more


Lovly earns scholarship grant for lung cancer research

Mar. 8, 2018—Christine Lovly, MD, PhD, assistant professor of Medicine at Vanderbilt, has received a $200,000 grant to support promising new research on lung cancer.

Read more


Research conducted by medical students recognized at events

Mar. 8, 2018—Vanderbilt-Ingram Cancer Center, Meharry Medical College and Tennessee State University Cancer Partnership recently hosted the 2018 annual retreat and poster contest, “Health Disparities in Cancer Immunology & Immune Therapy.”

Read more


Cancer immunotherapies expert Allison set for Discovery Lecture

Mar. 1, 2018—James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.

Read more


Page 1 of 3112345678...Last »

Upcoming Events

MORE EVENTS »